{"id":"c6affdb7-cbc2-57a9-8467-4d6e4e1c5a22","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:three-years-of-nsk-sd-does-not-slow-carotid-thickening","predicate":"does_not_change","statement":"Over a median three years at 2,000 FU per day, the annualized rate of change in carotid intima-media thickness did not differ from placebo.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"neutral","is_public":true,"mechanism_event_id":"50ba5df0-cfc3-53a0-9af0-f353c122de7f","mechanism_event_label":"Over a median three years at 2,000 FU per day, the annualized rate of change in carotid intima-media thickness did not differ from placebo.","subject":{"id":"9910223c-2a27-5d75-8003-91d72e71be9a","slug":"nsk-sd","display_name":"NSK-SD fermented soybean extract","entity_type_key":"chemical_species"},"object":{"id":"38b5e553-7784-5ea9-8bca-c48dd5075f74","slug":"carotid-intima-media-thickness","display_name":"Carotid artery intima-media thickness","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"50ba5df0-cfc3-53a0-9af0-f353c122de7f","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:three-years-of-nsk-sd-does-not-slow-carotid-thickening-event","event_type":"observed_intervention","label":"Over a median three years at 2,000 FU per day, the annualized rate of change in carotid intima-media thickness did not differ from placebo.","description":"Carotid artery ultrasound","status":"provisional","compartment":null,"participants":[{"entity":{"id":"9910223c-2a27-5d75-8003-91d72e71be9a","slug":"nsk-sd","display_name":"NSK-SD fermented soybean extract","entity_type_key":"chemical_species"},"role":"acting component","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"38b5e553-7784-5ea9-8bca-c48dd5075f74","slug":"carotid-intima-media-thickness","display_name":"Carotid artery intima-media thickness","entity_type_key":"cellular_process"},"role":"component the finding is about","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"duration","value_text":"Median 3 years","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human (265 randomized, median age 65.3, no clinical cardiovascular disease)","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Nattokinase, 2,000 fibrinolytic units per day","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Double-blinded and randomized, and by far the longest trial here. The null applies to this dose, this formulation, this low-risk population and these endpoints; it is not evidence that every product or dose is inert. It is also not an active-enzyme pharmacokinetic study.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"Human (265 randomized, median age 65.3, no clinical cardiovascular disease)","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Over a median three years at 2,000 FU per day, the annualized rate of change in carotid intima-media thickness did not differ from placebo.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Nattokinase atherothrombotic prevention study: A randomized controlled trial. (2021) https://pubmed.ncbi.nlm.nih.gov/33843667/ DOI: 10.3233/CH-211147","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vivo, oral","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Carotid artery ultrasound","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"e8a35237-68dc-5ddc-9b59-add057c7efd3","evidence_kind":"source_excerpt","locator":"Lines 1104-1104","start_line":1104,"end_line":1104,"excerpt":"Over a median three years at 2,000 FU per day, the annualized rate of change in carotid intima-media thickness did not differ from placebo.","model_system":"Human (265 randomized, median age 65.3, no clinical cardiovascular disease)","directness":"reported_statement","verification_status":"source_derived_draft","notes":"","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"41cb127c-1c23-53aa-b7d0-5ec7f6fa3c99","stable_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","document_type":"imported_text","citation_label":"Original AI-assisted curation built from a supplied entity-first document of 105 entities and 129 claims. Every reference in that document was resolved against live PubMed with its abstract read and its DOI cross-checked on 2026-09-23, and the EFSA novel-food opinion was retrieved and read in full. That check corrected two PMIDs that pointed at unrelated papers, two DOIs, and two papers recorded as carrying no erratum that do carry one; it also reversed three findings the supplied document had stated backwards. Two papers carry a published correction, recorded as such and not as a retraction. Three sources are not indexed in PubMed and are cited by what they have. Laboratory lineages are recorded, so the four papers from one group, the three from another and the two readings of a single applicant dossier cannot be counted as separate lines of support. Study-specific doses, units, populations and limitations retained; activity units are never converted between systems. Not publisher full text.","file_path":"","sha256":"34fc46e0e849d06bfa13cb099a79b50679dd6fd0de8a5a0575326afdde3259c1","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}